With Love: Using Promotoras for a Hispanic Community Palliative Care Promotora Palliative Care
1 other identifier
interventional
102
1 country
1
Brief Summary
Despite being strongly recommended, the integration of palliative care in oncology has not been widely adopted. Very few people have access to comprehensive palliative care. Access is even lower in rural and Hispanic communities. Even in communities with access, uptake is often low due to a lack of education on the part of both patients and providers regarding palliative care. This study aims to use an innovative approach to provide quality palliative care to oncology Hispanic patients by using community health workers also known as promotoras.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2018
CompletedStudy Start
First participant enrolled
May 8, 2018
CompletedFirst Posted
Study publicly available on registry
November 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 4, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedResults Posted
Study results publicly available
October 26, 2020
CompletedOctober 26, 2020
October 1, 2020
1.4 years
April 4, 2018
August 17, 2020
October 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Health Questionnaire - 9 (PHQ-9)
Patient Health Questionnaire -9 (PHQ-9); the score can range from 0 - 27; the lower score indicates a better outcome
The PHQ-9 was administered at baseline and then again about six weeks later when study participation is completed..
Functional Assessment of Chronic Illness Therapy - Palliative Care (FACIT-Pal)
Functional Assessment Chronic Illness Therapy (FACIT)-Palliative care (Pal), score range 0-184, a higher score means a better outcome.
The FACIT-Pal was administered at baseline and then again about six weeks later when study participation is completed.
Secondary Outcomes (2)
Emergency Department Visits
six weeks after enrollment
Intensive Care Unit Admissions
six weeks after enrollment
Study Arms (2)
Intervention (Promotora)
EXPERIMENTALThe intervention group will have three face-to-face meetings with the promotora. Participant will continue to receive the standard of care for his or her oncologic diagnosis as determined by his or her treating oncologist over the course of the study. During the study period, all participants will complete baseline, interim and exit surveys covering demographics, quality of life and pain management. Information pertaining to hospitalizations and emergency room visits will be obtained from their medical records and public health records.
Self-Education (Control)
NO INTERVENTIONParticipant will receive the standard of care for his or her oncologic diagnosis as determined by his or her treating oncologist over the course of the study. During the study period, all participants will complete baseline, interim and exit surveys covering demographics, quality of life and pain management. Information pertaining to hospitalizations and emergency room visits will be obtained from their medical records and public health records.
Interventions
If the patient is in the intervention group, the promotora will call the patient in order to invite them to a meeting. Meetings will be arranged by the promotora and the patients. A total of 2 group meetings will be required by all participants and 1 family meeting.
Eligibility Criteria
You may qualify if:
- Must be 18 years or older
- Must be a Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) or University Medical Center (UMC) El Paso patient
- Must be Hispanic
- Must have a cancer diagnosis
You may not qualify if:
- Under 17 years of age
- Not Hispanic
- Is not a patient of UMC or TTUHSC El Paso
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Tech University Health Sciences Center El Paso
El Paso, Texas, 79905, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Associate Director of Ob/Gyn Research
- Organization
- Texas Tech University Health Sciences Center at El Paso
Study Officials
- STUDY DIRECTOR
Christina Bracamontes, MS
Texas Tech University HSC El Paso
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2018
First Posted
November 8, 2018
Study Start
May 8, 2018
Primary Completion
October 4, 2019
Study Completion
June 30, 2020
Last Updated
October 26, 2020
Results First Posted
October 26, 2020
Record last verified: 2020-10